Back to Prosight Management, LP
Q3 2026 13F filing
Updated 9 days ago32 disclosed positions worth $515.5M
Portfolio value
$515.5M
Total holdings
32
New positions
0
Closed positions
0
Increased
0
Decreased
0
Turnover
—
Filed
2026-11-13
Full holdings
Every line item disclosed in Q3 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | G LAKEFRONT BIOTHERAPEUTICS NV | $59.3M | 2.00M | 11.49% | — |
| 2 | S SHATTUCK LABS INC | $52.2M | 7.65M | 10.12% | — |
| 3 | J JANUX THERAPEUTICS INC | $50.9M | 2.94M | 9.87% | — |
| 4 | N NEKTAR THERAPEUTICS | $47.5M | 785.0K | 9.22% | — |
| 5 | A ABIVAX SA | $37.3M | 376.8K | 7.24% | — |
| 6 | I INSMED INC | $27.2M | 238.1K | 5.27% | — |
| 7 | B BOSTON SCIENTIFIC CORP | $24M | 550.0K | 4.66% | — |
| 8 | I IRHYTHM HOLDINGS INC | $22.8M | 201.0K | 4.43% | — |
| 9 | A ALKERMES PLC | $22.3M | 550.0K | 4.32% | — |
| 10 | P PRIVIA HEALTH GROUP INC | $20.7M | 1.05M | 4.01% | — |
| 11 | M MINERALYS THERAPEUTICS INC | $20.1M | 800.0K | 3.90% | — |
| 12 | Z ZYMEWORKS INC | $19.1M | 721.1K | 3.71% | — |
| 13 | S SYNDAX PHARMACEUTICALS INC | $15.3M | 812.6K | 2.96% | — |
| 14 | K KURA ONCOLOGY INC | $13.7M | 1.27M | 2.65% | — |
| 15 | D DENALI THERAPEUTICS INC | $11.4M | 550.7K | 2.21% | — |
| 16 | P PRAXIS PRECISION MEDICINES I | $10.6M | 36.4K | 2.06% | — |
| 17 | H HEALTHEQUITY INC | $10.2M | 115.8K | 1.99% | — |
| 18 | B BRIDGEBIO PHARMA INC | $9.9M | 150.0K | 1.91% | — |
| 19 | A ALNYLAM PHARMACEUTICALS INC | $9.1M | 37.0K | 1.77% | — |
| 20 | H HUMANA INC | $8.4M | 22.0K | 1.63% | — |
| 21 | E ENOVIS CORPORATION | $4.9M | 267.4K | 0.95% | — |
| 22 | O ONKURE THERAPEUTICS INC | $3.6M | 1.33M | 0.70% | — |
| 23 | Q QUANTERIX CORP | $3.1M | 825.0K | 0.59% | — |
| 24 | G GENERATE BIOMEDICINES INC | $2.2M | 144.8K | 0.42% | — |
| 25 | ? N/A AN2 THERAPEUTICS INC | $1.9M | 350.9K | 0.36% | — |
| 26 | P PLIANT THERAPEUTICS INC | $1.7M | 1.60M | 0.34% | — |
| 27 | R ROCKET PHARMACEUTICALS INC | $1.6M | 595.0K | 0.30% | — |
| 28 | ? N/A REIN THERAPEUTICS INC | $1.3M | 1.66M | 0.26% | — |
| 29 | C COYA THERAPEUTICS INC | $1.2M | 229.6K | 0.22% | — |
| 30 | C CORBUS PHARMACEUTICALS HLDGS | $1.1M | 168.4K | 0.22% | — |
| 31 | I IMMUNEERING CORP | $614K | 150.0K | 0.12% | — |
| 32 | A ADC THERAPEUTICS SA | $488K | 399.9K | 0.09% | — |